Boston Scientific Receives FDA Approval For Promus Premier Everolimus ... HispanicBusiness.com By a News Reporter-Staff News Editor at Biotech Business Week -- Continuing to advance leading drug-eluting stent (DES) technology, Boston Scientific Corporation (NYSE: BSX) has received U.S. Food and Drug Administration (FDA) approval for the ... |
